Noninvasive Tests for NASH
Hear Stephen A. Harrison, MD, COL (Ret.), FAASLD, weigh the latest perspectives on wet biomarkers, imaging, and combination tests in NASH, including their use in:
• Diagnosis of NASH patients with NAS ≥ 4 and fibrosis ≥ F2
• Assessment of therapeutic response
• Assessment of long-term patient outcomes
Download the slides from this podcast at:
https://bit.ly/3il5rqG
See more NASH topics at:
https://bit.ly/3ezkBq6
